Insights

Innovative Cell Platforms Inceptor Bio’s proprietary OUTLAST platform and broad development pipeline in CAR-T, CAR-M, and NK/NKT therapies present significant opportunities to collaborate with biopharmaceutical companies seeking next-generation cell therapy solutions for difficult-to-treat cancers.

Strong Funding Momentum The recent $21M Series A2 funding milestone indicates investor confidence and provides capital for advancing clinical trials and expanding manufacturing capabilities, creating avenues for strategic partnerships and co-development deals to accelerate product commercialization.

Strategic Collaborations Inceptor Bio’s partnership with the University of Minnesota on IPSC platforms and its expansion plans for GMP manufacturing facilities suggest opportunities to integrate innovative cell production technologies with external partners or clients seeking reliable cell therapy manufacturing services.

Emerging Market Presence With recent company launches, website updates, and strategic leadership appointments, Inceptor Bio is positioning itself as an innovative player in the evolving cancer immunotherapy landscape, ideal for biotech companies, investors, and healthcare providers looking to stay ahead in next-generation oncology treatments.

Market Expansion Potential Although currently at a clinical and development stage with moderate revenue, Inceptor Bio’s focus on multi-platform therapies and expanding pipeline highlights potential for early engagement in partnership or licensing deals with larger biotech or pharma firms aiming to diversify their oncology portfolio.

Inceptor Bio Tech Stack

Inceptor Bio uses 8 technology products and services including cdnjs, oEmbed, HubSpot, and more. Explore Inceptor Bio's tech stack below.

cdnjs

Content Delivery Network

oEmbed

Dev Tools

HubSpot

Marketing Automation

Priority Hints

Performance

SiteGround

Platform As A Service

Google Analytics

Web Analytics

RankMath SEO

Web Platform Extensions

jQuery Waypoints

Web Tools And Plugins

Inceptor Bio Email Formats	Example	Percentage
First.Last@inceptor.bio	John.Doe@inceptor.bio	49%
First@inceptor.bio	John@inceptor.bio	1%
First.Last@inceptor.bio	John.Doe@inceptor.bio	49%
First@inceptor.bio	John@inceptor.bio	1%

Inceptor Bio Email Formats

Example

Percentage

First.Last@inceptor.bio

John.Doe@inceptor.bio

49%

First@inceptor.bio

John@inceptor.bio

First.Last@inceptor.bio

John.Doe@inceptor.bio

49%

First@inceptor.bio

John@inceptor.bio

Frequently Asked Questions

Where is Inceptor Bio's headquarters located?

Inceptor Bio's main headquarters is located at 2405 Perimeter Park Dr, Suite 200 Morrisville, North Carolina 27560, US. The company has employees across 2 continents, including North AmericaAfrica.

What is Inceptor Bio's official website and social media links?

Inceptor Bio's official website is inceptor.bio and has social profiles on LinkedIn Crunchbase.

What is Inceptor Bio's SIC code NAICS code?

Inceptor Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Inceptor Bio have currently?

As of October 2025, Inceptor Bio has approximately 23 employees across 2 continents, including North AmericaAfrica. Key team members include Chief Executive Officer: M. S.Chief Business Officer: A. M.Chief Scientific Officer: M. N.. Explore Inceptor Bio's employee directory with LeadIQ.

What industry does Inceptor Bio belong to?

Inceptor Bio operates in the Biotechnology Research industry.

What technology does Inceptor Bio use?

Inceptor Bio's tech stack includes cdnjsoEmbedHubSpotPriority HintsSiteGroundGoogle AnalyticsRankMath SEOjQuery Waypoints.

What is Inceptor Bio's email format?

Inceptor Bio's email format typically follows the pattern of First.Last@inceptor.bio. Find more Inceptor Bio email formats with LeadIQ.

When was Inceptor Bio founded?

Inceptor Bio was founded in 2020.

Inceptor Bio

Q: What is Inceptor Bio's official website and social media links?

Inceptor Bio's official website is inceptor.bio. Inceptor Bio has social profiles on LinkedIn.

Q: How many employees does Inceptor Bio have currently?

Inceptor Bio has approximately 23 employees.

Q: What technology does Inceptor Bio use?

Inceptor Bio's tech stack includes AOS, X-Content-Type-Options, Elementor, Google Cloud, Adobe Fonts.

Biotechnology ResearchUnited States11-50 Employees

Inceptor Bio is a clinical-stage biotech company pioneering next-generation cell therapies to cure cancer. Our proprietary OUTLAST™ platform reprograms T cells into persistent, stem-like cells capable of thriving in the hostile tumor microenvironment. 

Our thesis: Like elite athletes training at high elevation, T cells conditioned in challenging environments develop the attributes needed to thrive in the hostile tumor setting, outperforming cells grown in conventional, idealized conditions

Our lead program, IB-T101, is an autologous CD70 CAR-T therapy targeting clear cell Renal Cell Carcinoma (ccRCC).

Join us on our journey to redefine the future of cancer treatment.

Insights

Similar companies to Inceptor Bio

Roche

Bristol Myers Squibb

Sanofi

Takeda

Johnson & Johnson

Merck

Pfizer

AstraZeneca

Genentech

AbbVie

Biogen

Gilead Sciences

Novartis

Amgen

Inceptor Bio Tech Stack

Media & News

Inceptor Bio, LLC receives financing of $21M in Series A2.

Inceptor Bio, LLC launches website at inceptor.bio.

Inceptor Bio, LLC launches next-generation CAR-T, CAR-M, and NK/NKT platform.

Inceptor Bio, LLC is developing novel IPSC platform.

Inceptor Bio, LLC hired Matthias Schroff as Chief Executive Officer on Aug 24th '23.

Inceptor Bio, LLC invests into assets: Gainesville, FL GMP facility.

Inceptor Bio, LLC is developing CAR-T, CAR-M, and CAR-NK platforms.

Inceptor Bio's Email Address Formats